Category Archives: Stories of Hope

Stories

A difficult journey ends with a smile

The first smile of Bana Nizar Hassan, a nine-year-old Sudanese girl, after her surgery at Al Jalila Children’s Specialty Hospital, is a moment her father will never forget. Since birth, Bana has suffered from a complete failure of her left kidney and atrophy of her right kidney – a condition that affects one in 1,000 children.

Bana spent the first years of her life enduring all kinds of treatments and medications until it was finally decided that a kidney transplant would save her life.

After a long search for a donor and completing the necessary tests, Bana has become the first child to undergo kidney transplant surgery in Dubai, thanks to Al Jalila Foundation’s ‘Farah’ program.

Her case not only represented a significant medical achievement, but also reflected a model of cooperation between nine government and private health entities that worked in parallel to ensure a smooth and quick kidney transplant was carried out within the critical 12-hour window after the donor had passed away in Abu Dhabi.

Today, thanks to the surgery, Bana is able to lead a normal and healthy life.

Watch Bana’s Story of Hope here.

Scholarship recipient serves the nation

Dr Anas Al Salami is 1 of 4 outstanding Al Jalila Foundation Scholarship recipients to graduate as part of the ‘Class of 2018’ from Mohammed Bin Rashid University of Medicine and Healthcare Sciences (MBRU). In addition to earning a Masters of Paediatric Dentistry from MBRU, Dr Anas received the prestigious ‘Young Healthcare Professional Award’ by Dubai Healthcare City Authority. Dr Anas’ childhood dream was to become a dentist and through his academic career discovered his passion to serve as a Paediatric Dentist recognising that oral health and hygiene begins in infancy.

Dr Anas is highly recognised for breaking boundaries both locally and internationally by holding the highest score in the Tri-Collegiate Membership in Paediatric Dentistry Examination of the Royal College of Surgeons Edinburgh (2017) and the highest rank in MSc Pediatric Dentistry Program at MBRU (2017). In recognition of his outstanding achievements Dr Anas has recently been appointed as Lecturer & Specialist in Pediatric Dentistry at MBRU.

The young healthcare professional is an example as an academic, professional, volunteer and humanitarian. His achievements include providing oral health protocol to the Ministry of Interior for all jail nurseries in the UAE, and participating in initiatives like the Oral Health Camp for GCC Unified Week for oral care; Hamdan Bin Mohammed Oral Hygiene Initiative for Workers; Smile for Life Campaign; and Al Ihsan Charity Association oral health screening program for school children in Dubai.

Al Jalila Foundation has already awarded 59 scholarships to outstanding medical students in its mission to bolster the medical workforce in the UAE.

Marwa’s heart is filled with promise

Marwa, 21, had undergone a heart transplant in Germany where she stayed for more than 3 years after surgery to receive essential post-operative care.

Upon returning to the UAE it was vital, as part of the treatment plan for a post heart transplant, she continue to do regular follow-ups, catheter and heart biopsy, to check if there is a rejection of the new heart.

Lack of medical insurance posed a great difficulty and with such a serious medical condition it was imperative that Marwa undergo the necessary catheter procedure right away.

With Al Jalila Foundation’s support the treatment was carried out at Cleveland Clinic, Abu Dhabi with Dr Feras Bader who is the only doctor in the UAE able to perform this type of highly skilled specialist treatment.

Marwa expressed, “After many years of treatment away from home I was very physically and mentally tired and the support was everything I needed to continue to be strong and push through. I give great thanks and gratitude and the highest praise for the attention, care and help I received from Al Jalila Foundation and the medical team which is more than I can hope to repay.”

Read Marwa’s Story of Hope here.

Mohammed runs forward with hope

Mohammed Ayoub was one of our first A’awen patients, he was the face of 7EmiratesRun and the inspiration for Al Jalila Foundation’s iMcan program which provides prothesis to those in need.

6-year-old Mohammed was born with severe congenital limb deformities and over the years we have watched Mohammed blossom from a shy toddler into a confident young boy. He has since joined #TeamAlJalila at many events and even took part in the TECOM We Walk to inspire other children of determination.

Mohammed recently had the opportunity to be part of the Ottobock Running Clinic in Dubai run by Paralympic world champion and gold medalist, Heinrich Popow, and trialed a running prostheses for the first time. It has long been Mohammed’s wish to run and play football with his friends and siblings and when Mohammed put on the ‘running blade’ and was shown by Heinrich what he could do the thrill of being able to run freely was impossible to hide. Watching the Olympian and listening to his story of triumph and how he used his disability to the best of his ability, had Mohammed in awe and clearly made a lasting impression on the young boy. As the day came to an end Mohamed exclaimed “I want to run fast like Heinrich, I want to go to the Olympics”.

Since 1990 the UAE has been an avid champion for young children like Mohammed with sports being encouraged to all children of all abilities. In 2019 Abu Dhabi hosted the Special Olympics World Games and showed the world the UAE’s commitment to creating a more inclusive society and ensuring the happiness of people of determination so that children like Mohamed can realise their dreams. As we follow Mohammed’s journey he continues to inspire us with his childlike enthusiasm and ambition.

Saffron key in cancer treatment

According to the World Health Organization cancer is the second leading cause of death globally and researches around the world continue to search for a cure. Al Jalila Foundation research grant recipient, Professor Amr Amin from United Arab Emirates University, has been conducting a study since 2011 and found saffron to have anti-liver cancer properties working both to stop cell division and promote cell death. The study was first published in the Hepatology Journal. A multifaceted disease like cancer should be approached with therapies that target multiple biochemical and physiological pathways. Saffron has been used in folk medicine for centuries. Anticarcinogenic activity of saffron was reported at the beginning of 1990 and research on this subject has increasingly continued during the past decade.

Introduction of a natural compound-based active ingredient to the cancer therapeutics would be an advancement in relation to the serious issues of drug resistance, relapse, and effective dose, etc. Given the current limited treatment options for liver cancer, introducing safranal as a novel therapeutic drug against liver cancer is needed. With the same objective, Professor Amin’s study is assessing the anti-tumor properties of safranal with and without sorafenib in Hepatocellular carcinoma (HCC) cells and investigating the transcriptional and translational effects of safranal on angiogenesis of HCC cells.

Professor Amr’s study advocates that the active components of natural products can be curative and protective in a sense of evoking less side effects; thereby enhancing the efficiency of isolated or synthesized chemical compounds with the ultimate possibility to inhibit or even reverse tumor development.

Research tackles world’s greatest disease

According to the World Health Organisation, cardiovascular diseases are the number one cause of death globally and it is estimated that 30% of fatalities in the UAE are attributed to cardiovascular disease. While improvements in lifestyle can support successful treatment there is much research to be done to provide better treatment options.

Dr Maria Baias, Al Jalila Foundation grant recipient from New York University Abu Dhabi, is conducting a study to determine the structure of a new polymorph of aspirin using nuclear magnetic resonance crystallography.

This project will study the crystal structure of a new form of aspirin, which could have improved pharmaceutical properties and therefore be more effective in the prevention and treatment of cardiovascular diseases. Experimental and computational techniques will be combined to find an accurate crystal structure for this molecule from a pool of computationally predicted structures. The methodology used could, later on, be utilised to determine the structure of other important pharmaceutical compounds.

Click here to read about Al Jalila Foundation research.